Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Macrogol
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Glenmark Launches OTC Polyethylene Glycol 3350 Powder for Constipation Relief
Details : Glenmark Polyethylene Glycol 3350, Powder for Solution, which is generic version of MiraLAX. It is being indicated for occasional constipation.
Product Name : Polyethylene Glycol 3350
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 10, 2025
Lead Product(s) : Macrogol
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Macrogol,Maqui Berry Extract
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
NovaBay Pharmaceuticals Launches Avenova Bundles for Multifactorial Dry Eye Relief
Details : Avenova is a nutrient-rich, antioxidantdense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health.
Product Name : Avenova
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 13, 2024
Lead Product(s) : Macrogol,Maqui Berry Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Macrogol,Maqui Berry Extract
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Avenova is a nutrient-rich, antioxidantdense extract of the superfruit maqui berry, and high quality, natural triglyceride omega-3 oils to comfort dry eyes and support overall eye health.
Product Name : Avenova
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 03, 2023
Lead Product(s) : Macrogol,Maqui Berry Extract
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Macrogol
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Bausch & Lomb Incorporated
Deal Size : $106.5 million
Deal Type : Acquisition
Bausch + Lomb Expands OTC Product Line with Acquisition of Blink® Eye Drops
Details : Through the acquisition, Bausch & Lomb expands its OTC product line by obtaining Blink portfolio of eye drops including, Blink® Tears (polyethylene glycol).
Product Name : Blink® Tears
Product Type : Other Small Molecule
Upfront Cash : $106.5 million
June 07, 2023
Lead Product(s) : Macrogol
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Bausch & Lomb Incorporated
Deal Size : $106.5 million
Deal Type : Acquisition
Lead Product(s) : Macrogol,Polypropylene Glycol
Therapeutic Area : Ophthalmology
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : New Avenova (Polyethylene Glycol) lubricating eye drops are the first-line, go-to product for treating the symptoms of dry eye because they can provide immediate relief from the discomfort and pain that’s often associated with this common condition.
Product Name : Avenova
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 01, 2022
Lead Product(s) : Macrogol,Polypropylene Glycol
Therapeutic Area : Ophthalmology
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Macrogol
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Mochida Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : MOVICOL® HD is a high dose formulation of existing “MOVICOL® LD”, the first polyethylene glycol indicated for treatment of chronic constipation1) in Japan. MOVICOL® HD contains the same active ingredients in double the quantity of MOVICOL® LD per...
Product Name : Movicol HD
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 20, 2022
Lead Product(s) : Macrogol
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Mochida Pharmaceutical
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Macrogol,Electrolytes
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The investigational prep is designed to be good-tasting and easy-to-consume, with no fasting and lower fluid requirements than standard preps.
Product Name : Colonoscopy prep
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
July 21, 2020
Lead Product(s) : Macrogol,Electrolytes
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable